Prophylactic study for COVID-19 with Kampo medicines
Phase 3
Recruiting
- Conditions
- COVID-19Respiratory Tract Infections
- Registration Number
- JPRN-jRCTs031200150
- Lead Sponsor
- amiki Takao
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 6000
Inclusion Criteria
1) Age from 20 to 75 years old (at the time of registration)
2) Asymptomatic and body temperature below 37.0 degrees Celsius (at the time of registration)
3) Capable of eating orally
Exclusion Criteria
1)Previous upper respiratory inflammation due to viral infection (including suspected COVID-19)
2)Taking immunosuppressants
3)Allergic to any Kampo medicines
4)History of hypokalaemia, severe hypertension, severe liver dysfunction, and interstitial pneumonia
5)Regularly taking other Kampo medicines
6)Pregnant or possibly pregnant
7)Participating in other research
8)Judged to be unsuitable for this study by the doctor in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method